[Significance of local ablation therapy following portal embolization therapy for hepatocellular carcinoma with portal vein tumor thrombus].
We have performed ablation therapy for 4 patients who had hepatocellular carcinoma (HCC) with portal vein tumor thrombus (PVTT). In order to avoid intrahepatic metastasis due to ablation, we treated portal venous embolization before ablation. After treatment, computed tomography revealed no viable area in the treated lesion and no dissemination in the portal vein. A complication was encountered in 1 patient, in the form of a collection of ascites due to portal hypertension. We conclude that ablation therapy is the choice for unresectable HCC with PVTT in multidisciplinary therapy.
Doi
Koichi
K
Dept. of Digestive Surgery, Graduate School of Medicine, Kumamoto University.
Beppu
Toru
T
Ishiko
Takatoshi
T
Kai
Kazuharu
K
Maeda
Keisuke
K
Nakagawa
Masahide
M
Takahashi
Masashi
M
Egami
Hiroshi
H
Ogawa
Michio
M
D006528:Carcinoma, Hepatocellular / Q000601:surgery / Q000628:therapy*; D017115:Catheter Ablation; D003131:Combined Modality Therapy; D004621:Embolization, Therapeutic; D006801:Humans; D008113:Liver Neoplasms / Q000601:surgery / Q000628:therapy*; D009360:Neoplastic Cells, Circulating / Q000473:pathology*; D011169:Portal Vein; D013927:Thrombosis / Q000628:therapy*